Australia’s Neuren Pharma surges over 10% on US patent win for rare disease drug
Australia's Neuren Pharma surges over 10% on US patent win for rare disease drugSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com
Australia's Neuren Pharma surges over 10% on US patent win for rare disease drugSource: Investing.com
Microsoft, OpenAI clash over AGI clause in $10 bln deal – The InformationSource: Investing.com
Mars-Kellanova takeover not anticompetitive, FTC saysSource: Investing.com
Wall St futures flat amid Israel-Iran truce, Powell rate cautionSource: Investing.com

Tesla's robotaxi peppered with driving mistakes in Texas testsSource: Reuters

Meta fends off authors' US copyright lawsuit over AISource: Reuters

Mamdani lead in New York mayoral Democratic primary leaves businesses on edgeSource: Reuters

US FTC says Mars' $36 billion Kellanova deal is not anticompetitiveSource: Reuters

Microsoft and OpenAI dueling over artificial general intelligence, The Information reportsSource: Reuters
Enbridge says new Canadian oil pipeline would need legal reforms first - BloombergSource: Investing.com